UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000041980
Receipt No. R000047915
Scientific Title Examination of the effects of vegetable oil intake on immunity and mental and physical QOL (motivation, cognition, etc.) for healthy adult men and women who are worried about mental and physical deterioration due to aging
Date of disclosure of the study information 2021/12/27
Last modified on 2021/03/31 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Examination of the effects of vegetable oil intake on immunity and mental and physical QOL
Acronym Examination of the effects of vegetable oil intake on immunity and mental and physical QOL
Scientific Title Examination of the effects of vegetable oil intake on immunity and mental and physical QOL (motivation, cognition, etc.) for healthy adult men and women who are worried about mental and physical deterioration due to aging
Scientific Title:Acronym Examination of the effects of vegetable oil intake on immunity and mental and physical QOL (motivation, cognition, etc.) for healthy adult men and women who are worried about mental and physical deterioration due to aging
Region
Japan

Condition
Condition Healthy adult
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the effect of vegetable oil intake for 8 consecutive weeks on immunity and mental and physical QOL using placebo as a control
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes PASAT and Stroop before and after 8 weeks
Key secondary outcomes s-IgA and SF-36 before and after 8 weeks

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification NO
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Ingest vegetable oil for 8 consecutive weeks
Interventions/Control_2 Ingest placebo for 8 consecutive weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
40 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria (1) Healthy males and females from 40 years of age
(2) Subjects who are aware of the deterioration of memory due to aging
(3) Subjects with inferior scores of primary outcome
(4) Subjects with inferior score on the questionnaire
Key exclusion criteria (1) Subjects who regularly use health foods, etc. that contain many ingredients that may affect research results
(2) Subjects who have symptoms that affect the performance of the test
(3) Subjects having a disease requiring treatment or a history of serious diseases for which medication was required
(4) Subjects who have been diagnosed as menopausal symptoms
(5) Subjects who have depressive symptoms, or who have been diagnosed as depressive disorder
(6) Subjects who take medications that may affect research results
(7) Subjects who have diseases requiring regular administration, or who have severe diseases
(8) Subjects who sometimes have irregular lifestyles during the study
(9) Smokers or subjects who started smoking cessation within 12 months
(10) Subjects who have performed the same tests as the primary endpoint of this study within 12 months
(11) Subjects who have done blood transfusion or blood donation within 3 months
(12) Subjects who have participated in other clinical studies within 1 month, or who are planning to participate in other clinical studies during this study
(13) Subjects who are, or are planning to be pregnant or breastfeeding during study
(14) Subjects who are judged as unsuitable by doctor for laboratory value, anthropometric measurements, or physical examination value
(15) Subjects who are at risk of developing allergies related to research
(16) Subjects who are judged as unsuitable due to lifestyle questionnaire
(17) Subjects who are judged as unsuitable by doctor for other reasons
Target sample size 40

Research contact person
Name of lead principal investigator
1st name Sumio
Middle name
Last name Kondo
Organization Medical Corporation Kensho-kai, Fukushima Healthcare Center
Division name Internal Medicine, Department of Neurosurgery
Zip code 553-0004
Address 2-12-16 Tamagawa, Fukushima-ku, Osaka-shi, Osaka
TEL 06-6882-1130
Email s.kondo@drc-web.co.jp

Public contact
Name of contact person
1st name Kotoha
Middle name
Last name Isobe
Organization TTC Co., Ltd.
Division name Clinical Research Planning Department
Zip code 150-0021
Address Seibu Shinkin Bank Ebisu Bldg.,1-20-2, Ebisunishi, Shibuya-ku, Tokyo
TEL 03-5459-5329
Homepage URL
Email k.isobe@ttc-tokyo.co.jp

Sponsor
Institute TTC Co., Ltd
Institute
Department

Funding Source
Organization non-disclosure
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Medical Station Clinic Research Ethics Committee
Address 3-12-8, Takaban, Meguroku, Tokyo
Tel 03-6452-2712
Email t.saito@ttc-smo.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 12 Month 27 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2020 Year 09 Month 24 Day
Date of IRB
2020 Year 09 Month 24 Day
Anticipated trial start date
2020 Year 10 Month 05 Day
Last follow-up date
2020 Year 12 Month 27 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 10 Month 02 Day
Last modified on
2021 Year 03 Month 31 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047915